ABN Amro Investment Solutions Purchases Shares of 19,293 Centene Corporation $CNC

ABN Amro Investment Solutions bought a new stake in Centene Corporation (NYSE:CNC) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 19,293 shares of the company’s stock, valued at approximately $794,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CNC. Baird Financial Group Inc. acquired a new stake in shares of Centene in the 1st quarter valued at $236,000. Sivia Capital Partners LLC boosted its stake in shares of Centene by 80.0% in the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after purchasing an additional 4,315 shares in the last quarter. CW Advisors LLC boosted its stake in shares of Centene by 20.3% in the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock valued at $264,000 after purchasing an additional 820 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Centene by 6.1% in the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock valued at $2,440,000 after purchasing an additional 2,582 shares in the last quarter. Finally, Treasurer of the State of North Carolina boosted its stake in shares of Centene by 0.4% in the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock valued at $12,590,000 after purchasing an additional 967 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Performance

Centene stock opened at $59.15 on Monday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $60.76. The company has a market cap of $29.21 billion, a PE ratio of -4.50, a PEG ratio of 1.14 and a beta of 1.06. The company’s 50-day moving average is $43.06 and its two-hundred day moving average is $41.68.

Centene (NYSE:CNC) last released its earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $1.14. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The company had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. During the same period in the prior year, the company posted $2.90 EPS. The company’s revenue was up 7.1% compared to the same quarter last year. Equities analysts anticipate that Centene Corporation will post 3.45 earnings per share for the current year.

Analyst Ratings Changes

CNC has been the topic of several research reports. Zacks Research upgraded shares of Centene from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 6th. Barclays reiterated an “overweight” rating and set a $63.00 price target (up from $54.00) on shares of Centene in a research report on Wednesday, April 29th. Oppenheimer reiterated an “outperform” rating and set a $58.00 target price (up from $45.00) on shares of Centene in a research report on Wednesday, April 29th. Wall Street Zen upgraded shares of Centene from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Morgan Stanley upped their target price on shares of Centene from $45.00 to $50.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $56.94.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.